All Relations between dopaminergic and dopamine

Publication Sentence Publish Date Extraction Date Species
D M Donovan, D J Vandenbergh, M P Perry, G S Bird, R Ingersoll, E Nanthakumar, G R Uh. Human and mouse dopamine transporter genes: conservation of 5'-flanking sequence elements and gene structures. Brain research. Molecular brain research. vol 30. issue 2. 1995-09-13. PMID:7637582. these studies suggest sequence elements that are candidates to contribute to the dopamine transporter's dopaminergic cell-specific expression. 1995-09-13 2023-08-12 mouse
D M Severynse, A M Colapietro, T L Box, M G Caro. The human D1A dopamine receptor gene promoter directs expression of a reporter gene to the central nervous system in transgenic mice. Brain research. Molecular brain research. vol 30. issue 2. 1995-09-13. PMID:7637583. dopamine receptors are involved in many aspects of dopaminergic neurotransmission including regulation of motor control, cognition, affect and neuroendocrine function. 1995-09-13 2023-08-12 mouse
C Savy, F Moussafi, J Durand, J Yelnik, A Simon, J Nguyen-Legro. Distribution and spatial geometry of dopamine interplexiform cells in the retina. II. External arborizations in the adult rat and monkey. The Journal of comparative neurology. vol 355. issue 3. 1995-09-12. PMID:7636021. the morphology and distribution of dopaminergic interplexiform cells in adult rat and monkey retinas were analyzed to determine any correlation with the function of dopamine in the outer retinal layers. 1995-09-12 2023-08-12 rat
C Savy, F Moussafi, J Durand, J Yelnik, A Simon, J Nguyen-Legro. Distribution and spatial geometry of dopamine interplexiform cells in the retina. II. External arborizations in the adult rat and monkey. The Journal of comparative neurology. vol 355. issue 3. 1995-09-12. PMID:7636021. the function of the network of external processes from the interplexiform dopaminergic cells is discussed in terms of modulating the release of dopamine to external layers. 1995-09-12 2023-08-12 rat
A Scillitani, F Dicembrino, P Di Fazio, P P Vettori, V D'Angelo, T Scarabino, A Liuzz. In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas. The Journal of clinical endocrinology and metabolism. vol 80. issue 8. 1995-09-07. PMID:7629253. in vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (ibzm) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas. 1995-09-07 2023-08-12 Not clear
M Metra, C Missale, P F Spano, L D Ca. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine. Journal of cardiovascular pharmacology. vol 25. issue 5. 1995-09-05. PMID:7630152. dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine. 1995-09-05 2023-08-12 Not clear
M I Romero, C J Phelp. Prolactin replacement in adult dwarf mice does not reverse the deficit in tuberoinfundibular dopaminergic neuron number. Endocrinology. vol 136. issue 8. 1995-09-01. PMID:7543042. the lack of prl synthesis in ames dwarf mice coincides with a marked reduction in dopamine (da) and in numbers of prl-inhibiting tuberoinfundibular dopaminergic neurons in the hypothalamus (catecholaminergic area a12), as assessed by tyrosine hydroxylase (th) immunoreactivity. 1995-09-01 2023-08-12 mouse
S Bastianetto, L Rouquier, G Perrault, D J Sange. DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways. Neuropharmacology. vol 34. issue 3. 1995-09-01. PMID:7630482. the distribution of sigma sites in brain areas enriched in dopamine, and the finding that circling behaviour can be elicited by specific sigma ligands such as dtg (di-o-tolylguanidine) suggest a modulatory role of these sites in the dopaminergic system. 1995-09-01 2023-08-12 rat
N Vibert, M Serafin, O Crambes, P P Vidal, M Mühlethale. Dopaminergic agonists have both presynaptic and postsynaptic effects on the guinea-pig's medial vestibular nucleus neurons. The European journal of neuroscience. vol 7. issue 4. 1995-08-30. PMID:7620607. using intracellular recordings in brainstem slices, we have tested the effects of dopamine and other dopaminergic compounds on guinea-pig medial vestibular nucleus (mvn) neurons. 1995-08-30 2023-08-12 Not clear
N Vibert, M Serafin, O Crambes, P P Vidal, M Mühlethale. Dopaminergic agonists have both presynaptic and postsynaptic effects on the guinea-pig's medial vestibular nucleus neurons. The European journal of neuroscience. vol 7. issue 4. 1995-08-30. PMID:7620607. in normal medium, mvn neurons were depolarized by dopamine as well as by (-)quinpirole and piribedil, which are selective d2 dopaminergic agonists. 1995-08-30 2023-08-12 Not clear
N Vibert, M Serafin, O Crambes, P P Vidal, M Mühlethale. Dopaminergic agonists have both presynaptic and postsynaptic effects on the guinea-pig's medial vestibular nucleus neurons. The European journal of neuroscience. vol 7. issue 4. 1995-08-30. PMID:7620607. dopaminergic d1 receptors were apparently not involved in this effect since a selective d1 agonist, skf-38393, had no effect on mvn neurons and the d1 antagonist (+)sch-23390 could not block the effect of dopamine. 1995-08-30 2023-08-12 Not clear
F Fornai, M G Alessandrì, F Fascetti, F Vaglini, G U Corsin. Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice. Journal of neurochemistry. vol 65. issue 2. 1995-08-24. PMID:7616226. at the same time, evidence is accumulating that the endogenous noradrenergic system plays a protective role in mptp-induced striatal dopamine (da) depletion and nigral dopaminergic cell death. 1995-08-24 2023-08-12 mouse
T Akai, M Ozawa, M Yamaguchi, E Mizuta, S Kun. Behavioral involvement of central dopamine D1 and D2 receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned parkinsonian cynomolgus monkeys. Japanese journal of pharmacology. vol 67. issue 2. 1995-08-24. PMID:7616686. these results suggest that stimulation of either central dopamine d1 or d2 receptors is requisite for the antiparkinsonian effects and concurrent strong stimulation of both central dopamine d1 and d2 receptors causes marked hyperactivity which may be predictive of dopaminergic psychiatric side effects. 1995-08-24 2023-08-12 monkey
M Amalric, H Moukhles, A Nieoullon, A Daszut. Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat. The European journal of neuroscience. vol 7. issue 5. 1995-08-23. PMID:7613632. this lesion model, the induction of a partial dopamine denervation of the striatum (74% depletion of dopamine striatal tissue content) with a retrograde degeneration of dopamine cell bodies in the substantia nigra, sparing the mesolimbic dopaminergic pathway, closely approximates the neuronal degeneration observed in human idiopathic parkinson's disease. 1995-08-23 2023-08-12 human
B J Johnson, J P Brun. Dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates. Neuropharmacology. vol 34. issue 2. 1995-08-23. PMID:7617145. dopaminergic modulation of striatal acetylcholine release in rats depleted of dopamine as neonates. 1995-08-23 2023-08-12 rat
T Himi, M Cao, N Mor. Reduced expression of the molecular markers of dopaminergic neuronal atrophy in the aging rat brain. The journals of gerontology. Series A, Biological sciences and medical sciences. vol 50. issue 4. 1995-08-18. PMID:7614230. expression of mrnas encoding the dopamine transporter (dat) and tyrosine hydroxylase (th) in dopaminergic neurons of the substantia nigra (sn) was examined in young and aged fischer 344 rats by in situ hybridization. 1995-08-18 2023-08-12 rat
A Bourson, E Borroni, R H Austin, F J Monsma, A J Sleigh. Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides. The Journal of pharmacology and experimental therapeutics. vol 274. issue 1. 1995-08-18. PMID:7616396. the specific behavioral syndrome did not appear to be caused by modulation of dopaminergic neurotransmission since no changes in the tissue levels of either dopamine or its metabolites 3,4-dihydroxyphenylacetic acid and homovanillic acid were seen. 1995-08-18 2023-08-12 rat
D Wheeler, M G Boutelle, M Fillen. The role of N-methyl-D-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience. vol 65. issue 3. 1995-08-17. PMID:7609875. this suggests that phasic increases in striatal dopamine release are triggered by the action of glutamate on dopaminergic nerve terminals. 1995-08-17 2023-08-12 rat
T P Shevchenko, B A Tolpyshev, A A Dutov, L I Povaliaev. [Analysis of functional and biochemical changes in feline cerebral hemispheres after subchronic haloperidol administration]. Patologicheskaia fiziologiia i eksperimental'naia terapiia. issue 1. 1995-08-15. PMID:7609996. feline experiments have revealed that subchronic haloperidol causes asymmetric changes in the mesencephalic levels of dopamine and serotonin and impairs intrahemispheric balance between the dopaminergic and serotoninergic systems. 1995-08-15 2023-08-12 Not clear
J S Schneider, L DiStefan. Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments. Brain research. vol 674. issue 2. 1995-08-03. PMID:7796105. these results confirm previous findings that gm1 provides trophic support for damaged dopamine neurons and suggests that gm1, fgf-2, and egf may also enhance dopaminergic function in residual neurons. 1995-08-03 2023-08-12 mouse